FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37520083> ?p ?o ?g. }

• Q37520083 description "article científic" @default.
• Q37520083 description "article scientifique" @default.
• Q37520083 description "articolo scientifico" @default.
• Q37520083 description "artigo científico" @default.
• Q37520083 description "artículu científicu espublizáu en 2016" @default.
• Q37520083 description "bilimsel makale" @default.
• Q37520083 description "scientific article published on 19 July 2016" @default.
• Q37520083 description "vedecký článok" @default.
• Q37520083 description "vetenskaplig artikel" @default.
• Q37520083 description "videnskabelig artikel" @default.
• Q37520083 description "vědecký článek" @default.
• Q37520083 description "wetenschappelijk artikel" @default.
• Q37520083 description "wissenschaftlicher Artikel" @default.
• Q37520083 description "наукова стаття, опублікована в липні 2016" @default.
• Q37520083 description "научни чланак" @default.
• Q37520083 description "مقالة علمية نشرت في 19 يوليو 2016" @default.
• Q37520083 name "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 name "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 name "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 type Item @default.
• Q37520083 label "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 label "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 label "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 prefLabel "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 prefLabel "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 prefLabel "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 P1433 Q37520083-EFCF5AC9-0E6D-481E-B4EC-C1AB3A2C1922 @default.
• Q37520083 P1476 Q37520083-FD43C8A4-9C18-4F4C-9B92-F9FE86D3C75A @default.
• Q37520083 P2093 Q37520083-1B942463-708C-47B9-9F4A-823B75FD3659 @default.
• Q37520083 P2093 Q37520083-221C386F-8C50-4476-A41D-080B23AEE68B @default.
• Q37520083 P2093 Q37520083-44E433D8-C88B-4690-A06C-D408E5ED4551 @default.
• Q37520083 P2093 Q37520083-4F29C277-DDF2-469B-8A6C-07D10BF5D854 @default.
• Q37520083 P2093 Q37520083-572D8FFE-D538-464C-ADAB-2B96C2AF9841 @default.
• Q37520083 P2093 Q37520083-72BC642B-8090-4A49-B67A-DEA640521CE7 @default.
• Q37520083 P2093 Q37520083-73BED411-8EBB-46B6-9E86-4291A127CBB9 @default.
• Q37520083 P2093 Q37520083-8FF98E0F-9CB4-4EE8-B2AF-66B49345D26E @default.
• Q37520083 P2093 Q37520083-B62A79E7-E8A5-4D03-8B14-6DB9DFC76392 @default.
• Q37520083 P2093 Q37520083-BB547A33-FAE7-4F44-BD13-0D0E5099E488 @default.
• Q37520083 P2093 Q37520083-D1EA26AB-9FF3-4141-A2AB-6301DCEDAAB6 @default.
• Q37520083 P2093 Q37520083-D58E6841-7E6A-4826-B72A-FF00A42CE855 @default.
• Q37520083 P2093 Q37520083-EFD7D54E-DD21-4E4C-B28B-9161A1B44A9F @default.
• Q37520083 P2860 Q37520083-0B85FCBD-FEF1-4A8D-ACDE-09027CC96DD8 @default.
• Q37520083 P2860 Q37520083-146E5589-CB5E-49EA-97B5-652D159E7225 @default.
• Q37520083 P2860 Q37520083-15B2AFB0-BC9A-433D-8D4D-24726216EA5D @default.
• Q37520083 P2860 Q37520083-18CE7730-6A6F-418D-B103-A832B50FC923 @default.
• Q37520083 P2860 Q37520083-1D78C88D-D85A-43BA-89EF-3F920BFF00A9 @default.
• Q37520083 P2860 Q37520083-280BEC29-F81F-474D-819F-9AE2566B94DD @default.
• Q37520083 P2860 Q37520083-2BEBD423-77E6-447F-ACC4-16EC0DFCC90E @default.
• Q37520083 P2860 Q37520083-3B835CF6-76EA-4F98-8F1C-EEC7A30DA2E9 @default.
• Q37520083 P2860 Q37520083-3BA0BC87-4D92-4995-A217-3D4C0B6B480A @default.
• Q37520083 P2860 Q37520083-4549074C-478E-49EF-A586-B94AAD9315FC @default.
• Q37520083 P2860 Q37520083-50A7E052-92AC-4BE2-931D-9A867CDC2780 @default.
• Q37520083 P2860 Q37520083-51F0B098-8FAF-4BD3-828B-C8475105BE73 @default.
• Q37520083 P2860 Q37520083-5B142523-122C-47A7-83D7-FFA986BAC06B @default.
• Q37520083 P2860 Q37520083-616FDE75-B8D7-446C-9CDB-18622D0A029F @default.
• Q37520083 P2860 Q37520083-623339F0-C294-46EC-AD8F-FF1A2359B893 @default.
• Q37520083 P2860 Q37520083-62DD5ACA-4044-43C2-87F2-8F77FCEC4ADB @default.
• Q37520083 P2860 Q37520083-7B0AAC46-9E85-4143-A074-5AA1E4775194 @default.
• Q37520083 P2860 Q37520083-7B78B75C-3B7B-4932-B9DE-A6631B6BCC97 @default.
• Q37520083 P2860 Q37520083-82CAC933-4DE5-4E29-B6AB-F5033005D371 @default.
• Q37520083 P2860 Q37520083-86056B16-AF19-4DCF-896F-0CF5E6E2AA05 @default.
• Q37520083 P2860 Q37520083-8FA169F7-A639-42ED-9528-656396FD441D @default.
• Q37520083 P2860 Q37520083-9049396A-4B7C-45AC-8E59-DB2F016BB9E4 @default.
• Q37520083 P2860 Q37520083-98558AD8-EB3C-4540-BEBE-141DDC235271 @default.
• Q37520083 P2860 Q37520083-9895BC51-920C-4736-8224-98FD685A7B9D @default.
• Q37520083 P2860 Q37520083-9EE43CA4-F858-4860-B5A6-61772A2595C5 @default.
• Q37520083 P2860 Q37520083-A323DBF2-7DEC-4694-8120-1ADFD249FAF4 @default.
• Q37520083 P2860 Q37520083-AF123810-8ADC-4E75-AEF8-975AE442B4A1 @default.
• Q37520083 P2860 Q37520083-B2BB5A4A-E141-4AEF-BB26-EAF09536BCF7 @default.
• Q37520083 P2860 Q37520083-B7FB7A37-658D-4D1B-A372-8C5045BDDD5D @default.
• Q37520083 P2860 Q37520083-C4BB3B56-F46B-49CC-8001-E7BF1ACC2F75 @default.
• Q37520083 P2860 Q37520083-C9E37FBA-E03D-4830-A511-B44B9DB9F8DE @default.
• Q37520083 P2860 Q37520083-CA9D827A-069C-4D30-8ED4-3AF09F40DCBB @default.
• Q37520083 P2860 Q37520083-CB0AC08A-53A8-4C44-8468-4B8C0747CF17 @default.
• Q37520083 P2860 Q37520083-CCCA1A91-A065-4D05-8B85-2A4CEF64CFC4 @default.
• Q37520083 P2860 Q37520083-CF83AC65-024A-4818-A1ED-F3836ED3039B @default.
• Q37520083 P2860 Q37520083-D700D743-7E7A-4C17-8EDD-8BEF8655CD5C @default.
• Q37520083 P2860 Q37520083-D9754B2D-A9AC-4C26-935B-A33C539AF4AD @default.
• Q37520083 P2860 Q37520083-E13CE327-A7B0-4F11-832C-4F91D5B7A187 @default.
• Q37520083 P2860 Q37520083-E4A1B280-90B7-4964-AFAD-1F47CECA2324 @default.
• Q37520083 P2860 Q37520083-E690675D-9101-4702-BB28-6AEB6EDB3C26 @default.
• Q37520083 P2860 Q37520083-ED43C6D9-CCE5-4661-A2BA-E122B456AD2C @default.
• Q37520083 P2860 Q37520083-EF8E6D03-B05D-45B6-B3B2-D5C564052C16 @default.
• Q37520083 P304 Q37520083-B61FDB64-92CD-4FD7-89C1-9CD428E7B5EA @default.
• Q37520083 P31 Q37520083-83A41755-17E6-4619-AB57-0D0C13C25B94 @default.
• Q37520083 P356 Q37520083-77D6CFD0-648F-4F54-B06A-DDCF69694260 @default.
• Q37520083 P407 Q37520083-B34AB510-FC5C-4561-ABF3-92C949658CF0 @default.
• Q37520083 P433 Q37520083-65BEECFC-EAE6-4E99-AD81-8210A7AE4DEE @default.
• Q37520083 P478 Q37520083-64B791FE-426C-45D7-832B-A4CB73091E73 @default.
• Q37520083 P577 Q37520083-F7E0C371-D196-4552-8C0E-AD894EFD1830 @default.
• Q37520083 P698 Q37520083-A05AE4EC-016B-49D0-A476-30F06B4EEBD4 @default.
• Q37520083 P921 Q37520083-6A4F487B-1274-4346-9A48-A69BB88C9EA6 @default.
• Q37520083 P921 Q37520083-F326BFCD-C08E-4158-A224-2B866E189D4F @default.
• Q37520083 P932 Q37520083-0664BC19-C644-4B0D-8596-CD68D27329AD @default.
• Q37520083 P356 QAI.0000000000001136 @default.
• Q37520083 P698 27437826 @default.
• Q37520083 P1433 Q6294722 @default.
• Q37520083 P1476 "First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics" @default.
• Q37520083 P2093 "Barbara A Friedland" @default.
• Q37520083 P2093 "Craig J Hoesley" @default.

• next